Future Robotics
About
The combination of artificial intelligence in the form of robots, combined with human experience and knowledge, will shape the pharmaceutical industry in the coming years.
What options are there for automating manufacturing processes and controlling process sequences reliably and reproducibly?
What will pharmaceutical production and laboratory activities look like in a few years?
+ Automation
+ Robot technologies
+ Robots and Cobots*
+ Concepts and
+ solutions
+ Future
+ processes
The result
Manager
Richard Denk
Chair SIG Future Robotics
(SKAN AG)
Steering Committee
Christian Arends,
Schott
Birger Bockius,
Merck
Carl-Helmut Coulon,
INVITE GmbH, Co Chair
Richard Denk,
SKAN AG, Chair
Luc Graber,
Philip Morris
Thomas Ryu Gruber,
Pfizer
Svenja Gutsche,
Bayer AG
Christine Eckardt,
PM Group
David Wolton,
Takeda
Miguel Alvarino,
Company Lonza CH
Thorsten Häfner
Groningen
Thorsten Kimmel,
Roche
Stefan Kurz,
Bayer AG
Florian Runner,
Roche
Ruben Brandes,
WDT
Julien Janda,
Takeda
Christopher Essert,
Company Essert D
Arno Schroff,
Cousin Pharma
Patrick Springer,
Legacypharm
Markus Stübchen,
Roche
Fabian Stutz,
Pharmabotix AG
Thomas Thurn,
Cilag/J&J
Josef Trapl,
Takeda
Markus Zeitz,
Novartis
Andreas Kleiner,
Boehringer Ingelheim
Adam Hawthorne,
PM Group
Jochen Radmer,
Bayer AG
Antje Schmelzer,
Boehringer Ingelheim
Andrea Neumüller,
Lonza